# Gaia, Inc: financial statements, quarterly

GAIA · Nasdaq · CIK 1089872 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gaia.md) · [Financials](/companies/gaia/financials.md) · [Filings](/companies/gaia/filings.md) · [Insiders](/companies/gaia/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gaia/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [20.2](/filings/0000950170-24-120784.md) | [20.7 d](/filings/0000950170-25-036287.md) | [21.3](/filings/0000950170-25-069238.md) | [21.9](/filings/0000950170-25-106575.md) | [22.0](/filings/0001193125-25-263669.md) | [24.1 d](/filings/0001193125-26-096522.md) | [23.8](/filings/0001193125-26-203986.md) | [24.6](/filings/0001193125-26-342379.md) | [25.0](/filings/0001193125-25-263669.md) | [25.5 d](/filings/0001193125-26-096522.md) | [24.3](/filings/0001193125-26-203986.md) | [23.3](/filings/0001193125-26-342379.md) |
| Cost of revenue | $m | [3.0](/filings/0000950170-24-120784.md) | [3.0 d](/filings/0000950170-25-036287.md) | [3.1](/filings/0000950170-25-069238.md) | [3.4](/filings/0000950170-25-106575.md) | [3.1](/filings/0001193125-25-263669.md) | [2.8 d](/filings/0001193125-26-096522.md) | [2.9](/filings/0001193125-26-203986.md) | [3.3](/filings/0001193125-26-342379.md) | [3.4](/filings/0001193125-25-263669.md) | [3.2 d](/filings/0001193125-26-096522.md) | [3.4](/filings/0001193125-26-203986.md) | [3.4](/filings/0001193125-26-342379.md) |
| Gross profit | $m | [17.2](/filings/0000950170-24-120784.md) | [17.7 d](/filings/0000950170-25-036287.md) | [18.2](/filings/0000950170-25-069238.md) | [18.5](/filings/0000950170-25-106575.md) | [19.0](/filings/0001193125-25-263669.md) | [21.3 d](/filings/0001193125-26-096522.md) | [20.9](/filings/0001193125-26-203986.md) | [21.3](/filings/0001193125-26-342379.md) | [21.6](/filings/0001193125-25-263669.md) | [22.3 d](/filings/0001193125-26-096522.md) | [20.9](/filings/0001193125-26-203986.md) | [19.9](/filings/0001193125-26-342379.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(0.4)](/filings/0000950170-24-120784.md) | [(1.5) d](/filings/0000950170-25-036287.md) | [(0.9)](/filings/0000950170-25-069238.md) | [(2.0)](/filings/0000950170-25-106575.md) | [(1.2)](/filings/0001193125-25-263669.md) | [(1.7) d](/filings/0001193125-26-096522.md) | [(1.0)](/filings/0001193125-26-203986.md) | [(2.2)](/filings/0001193125-26-342379.md) | [(1.2)](/filings/0001193125-25-263669.md) | [(0.7) d](/filings/0001193125-26-096522.md) | [(1.4)](/filings/0001193125-26-203986.md) | [(3.2)](/filings/0001193125-26-342379.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001193125-26-203986.md) | [0.0](/filings/0001193125-26-342379.md) | [0.0](/filings/0001193125-25-263669.md) | [0.1 d](/filings/0001193125-26-096522.md) | [0.0](/filings/0001193125-26-203986.md) | [(0.0)](/filings/0001193125-26-342379.md) |
| Net income | $m | [(0.7)](/filings/0000950170-24-120784.md) | [(1.8) d](/filings/0000950170-25-036287.md) | [(1.0)](/filings/0000950170-25-106575.md) | [(2.2)](/filings/0000950170-25-106575.md) | [(1.2)](/filings/0001193125-25-263669.md) | [(0.8) d](/filings/0001193125-26-096522.md) | [(1.0)](/filings/0001193125-26-203986.md) | [(1.8)](/filings/0001193125-26-342379.md) | [(1.2)](/filings/0001193125-25-263669.md) | [(0.5) d](/filings/0001193125-26-096522.md) | [(1.3)](/filings/0001193125-26-203986.md) | [(3.0)](/filings/0001193125-26-342379.md) |
| Diluted EPS | $ per share | [(0.04)](/filings/0000950170-24-120784.md) | not reported | [(0.05)](/filings/0000950170-25-069238.md) | [(0.09)](/filings/0000950170-25-106575.md) | [(0.05)](/filings/0001193125-25-263669.md) | not reported | [(0.04)](/filings/0001193125-26-203986.md) | [(0.07)](/filings/0001193125-26-342379.md) | [(0.05)](/filings/0001193125-25-263669.md) | not reported | [(0.05)](/filings/0001193125-26-203986.md) | [(0.12)](/filings/0001193125-26-342379.md) |
| Basic EPS | $ per share | [(0.04)](/filings/0000950170-24-120784.md) | not reported | [(0.05)](/filings/0000950170-25-069238.md) | [(0.09)](/filings/0000950170-25-106575.md) | [(0.05)](/filings/0001193125-25-263669.md) | not reported | [(0.04)](/filings/0001193125-26-203986.md) | [(0.07)](/filings/0001193125-26-342379.md) | [(0.05)](/filings/0001193125-25-263669.md) | not reported | [(0.05)](/filings/0001193125-26-203986.md) | [(0.12)](/filings/0001193125-26-342379.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [11.2](/filings/0000950170-23-056400.md) | [7.8](/filings/0000950170-25-036287.md) | [8.6](/filings/0000950170-24-053529.md) | [5.5](/filings/0000950170-24-090814.md) | [4.4](/filings/0000950170-24-120784.md) | [5.9](/filings/0001193125-26-096522.md) | [13.1](/filings/0000950170-25-069238.md) | [13.9](/filings/0000950170-25-106575.md) | [14.2](/filings/0001193125-25-263669.md) | [13.5](/filings/0001193125-26-342379.md) | [13.1](/filings/0001193125-26-203986.md) | [5.3](/filings/0001193125-26-342379.md) |
| Current assets | $m | [19.2](/filings/0000950170-23-056400.md) | [16.1](/filings/0000950170-25-036287.md) | [21.5](/filings/0000950170-24-053529.md) | [15.6](/filings/0000950170-24-090814.md) | [14.4](/filings/0000950170-24-120784.md) | [15.7](/filings/0001193125-26-096522.md) | [24.2](/filings/0000950170-25-069238.md) | [23.5](/filings/0000950170-25-106575.md) | [23.5](/filings/0001193125-25-263669.md) | [22.5](/filings/0001193125-26-342379.md) | [22.0](/filings/0001193125-26-203986.md) | [14.6](/filings/0001193125-26-342379.md) |
| Total assets | $m | [135](/filings/0000950170-24-038768.md) | [130](/filings/0000950170-25-036287.md) | [134](/filings/0000950170-24-053529.md) | [142](/filings/0000950170-24-090814.md) | [140](/filings/0000950170-24-120784.md) | [141](/filings/0001193125-26-096522.md) | [149](/filings/0000950170-25-069238.md) | [147](/filings/0000950170-25-106575.md) | [151](/filings/0001193125-25-263669.md) | [155](/filings/0001193125-26-342379.md) | [155](/filings/0001193125-26-203986.md) | [148](/filings/0001193125-26-342379.md) |
| Current liabilities | $m | [39.3](/filings/0000950170-23-056400.md) | [31.4](/filings/0000950170-25-036287.md) | [35.9](/filings/0000950170-24-053529.md) | [34.8](/filings/0000950170-24-090814.md) | [33.8](/filings/0000950170-24-120784.md) | [41.8](/filings/0001193125-26-096522.md) | [43.2](/filings/0000950170-25-069238.md) | [43.4](/filings/0000950170-25-106575.md) | [44.8](/filings/0001193125-25-263669.md) | [38.0](/filings/0001193125-26-342379.md) | [39.2](/filings/0001193125-26-203986.md) | [35.5](/filings/0001193125-26-342379.md) |
| Total liabilities | $m | [51.6](/filings/0000950170-23-056400.md) | [43.5](/filings/0000950170-25-036287.md) | [47.7](/filings/0000950170-24-053529.md) | [46.4](/filings/0000950170-24-090814.md) | [45.1](/filings/0000950170-24-120784.md) | [47.2](/filings/0001193125-26-096522.md) | [48.4](/filings/0000950170-25-069238.md) | [48.4](/filings/0000950170-25-106575.md) | [49.6](/filings/0001193125-25-263669.md) | [52.5](/filings/0001193125-26-342379.md) | [53.5](/filings/0001193125-26-203986.md) | [49.6](/filings/0001193125-26-342379.md) |
| Long-term debt | $m | [5.8](/filings/0000950170-23-056400.md) | [5.8](/filings/0000950170-25-036287.md) | [5.8](/filings/0000950170-24-053529.md) | [5.7](/filings/0000950170-24-090814.md) | [5.7](/filings/0000950170-24-120784.md) | [0.0](/filings/0000950170-25-036287.md) | not reported | not reported | not reported | [5.5](/filings/0001193125-26-342379.md) | [5.4](/filings/0001193125-26-203986.md) | [5.3](/filings/0001193125-26-342379.md) |
| Current portion of debt | $m | [9.9](/filings/0000950170-23-056400.md) | [0.2](/filings/0000950170-25-036287.md) | [0.2](/filings/0000950170-24-053529.md) | [0.2](/filings/0000950170-24-090814.md) | [0.2](/filings/0000950170-24-120784.md) | [5.8](/filings/0001193125-26-096522.md) | [5.8](/filings/0000950170-25-069238.md) | [5.7](/filings/0000950170-25-106575.md) | [5.7](/filings/0001193125-25-263669.md) | [0.2](/filings/0001193125-26-342379.md) | [0.2](/filings/0001193125-26-203986.md) | [0.2](/filings/0001193125-26-342379.md) |
| Shareholders' equity | $m | [82.1](/filings/0000950170-24-038768.md) | [85.5](/filings/0000950170-25-036287.md) | [84.8](/filings/0000950170-24-053529.md) | [82.1](/filings/0000950170-24-090814.md) | [81.2](/filings/0000950170-24-120784.md) | [80.7](/filings/0001193125-26-096522.md) | [87.0](/filings/0000950170-25-069238.md) | [85.7](/filings/0000950170-25-106575.md) | [86.3](/filings/0001193125-25-263669.md) | [87.9](/filings/0001193125-26-342379.md) | [87.0](/filings/0001193125-26-203986.md) | [84.3](/filings/0001193125-26-342379.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent, us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [1,415 d](/filings/0000950170-24-120784.md) | [3,185 d](/filings/0000950170-25-036287.md) | [5,936](/filings/0000950170-25-069238.md) | [(2,081) d](/filings/0000950170-25-106575.md) | [409 d](/filings/0001193125-25-263669.md) | [2,659 d](/filings/0001193125-26-096522.md) | [1,298](/filings/0001193125-26-203986.md) | [2,284 d](/filings/0001193125-26-342379.md) | [326 d](/filings/0001193125-25-263669.md) | [1,766 d](/filings/0001193125-26-096522.md) | [1,493](/filings/0001193125-26-203986.md) | [(5,379) d](/filings/0001193125-26-342379.md) |
| Capital expenditure | $k | [1,066 d](/filings/0000950170-24-120784.md) | [2,299 d](/filings/0000950170-25-036287.md) | [1,073](/filings/0000950170-25-069238.md) | [1,447 d](/filings/0000950170-25-106575.md) | [1,361 d](/filings/0001193125-25-263669.md) | [1,101 d](/filings/0001193125-26-096522.md) | [1,030](/filings/0001193125-26-203986.md) | [1,404 d](/filings/0001193125-26-342379.md) | [1,927 d](/filings/0001193125-25-263669.md) | [1,690 d](/filings/0001193125-26-096522.md) | [1,624](/filings/0001193125-26-203986.md) | [2,512 d](/filings/0001193125-26-342379.md) |
| Dividends paid | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [20.8](/filings/0000950170-23-056400.md) | [20.8](/filings/0000950170-24-053529.md) | [20.9](/filings/0000950170-24-090814.md) | [21.2](/filings/0000950170-24-120784.md) | [23.2](/filings/0000950170-25-069238.md) | [23.4](/filings/0000950170-25-106575.md) | [23.4](/filings/0001193125-25-263669.md) | [24.3](/filings/0001193125-26-203986.md) | [25.0](/filings/0001193125-26-342379.md) | [25.0](/filings/0001193125-25-263669.md) | [25.0](/filings/0001193125-26-203986.md) | [25.0](/filings/0001193125-26-342379.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.